Results 101 to 110 of about 21,364 (194)
ABSTRACT Pharmacologic interventions for type 1 diabetes (T1D) have advanced significantly in recent years with the advent of the first FDA approved therapy teplizumab for delaying symptomatic disease onset in 2022. Despite this progress, major hurdles remain in moving toward personalized medicine approaches for T1D.
Jasmine Pipella, Peter J. Thompson
wiley +1 more source
Islet transplantation : The quest for an ideal source
The progress of islet transplantation as a new therapy for patients with diabetes mellitus depends directly upon the development of efficient and practical immunoisolation methods for the supply of sufficient quantities of islet cells.
Younes Nidal +2 more
doaj
Despite insulin therapy, 18.8 and 7.8% of the patients experienced diabetic ketosis and diabetic ketoacidosis, respectively. Furthermore, 12.7 and 28.9% of the participants experienced severe hypoglycemia and hypoglycemic unawareness, respectively. Lower C‐peptide levels were associated with the incidence of these complications.
Daisuke Chujo +7 more
wiley +1 more source
Strategy for Clinical Setting of Co-transplantation of Mesenchymal Stem Cells and Pancreatic Islets
Islet transplantation may be the most efficient therapeutic technique for patients with type 1 diabetes mellitus (T1DM). However, the clinical application of this method is faced with numerous limitations, including isolated islet apoptosis, recipient ...
Liang Mei +6 more
doaj +1 more source
Islet Cell Transplantation [PDF]
Terry, Samuel, Paul, Cockwell
openaire +2 more sources
Editorial for Special Issue "Islet Transplantation". [PDF]
Matsumoto S.
europepmc +1 more source

